Key terms
About WVE
Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest WVE news
Apr 01
7:21am ET
Analysts’ Top Healthcare Picks: Wave Life Sciences (WVE), Passage Bio (PASG)
Apr 01
7:21am ET
Truist Financial Reaffirms Their Buy Rating on Wave Life Sciences (WVE)
Mar 12
6:41am ET
Wave Life Sciences price target raised to $19 from $10 at Mizuho
Mar 11
2:40am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Illumina (ILMN), MoonLake Immunotherapeutics (MLTX) and Wave Life Sciences (WVE)
Mar 11
1:10am ET
Analysts Are Bullish on These Healthcare Stocks: Wave Life Sciences (WVE), Dexcom (DXCM)
Mar 07
9:31am ET
Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA), Brainsway (BWAY) and Wave Life Sciences (WVE)
Mar 07
6:06am ET
Wave Life Sciences price target raised to $15 from $8 at H.C. Wainwright
Mar 06
7:52am ET
Wave Life Sciences Unveils New Corporate Presentation
Mar 06
7:33am ET
Wave Life Sciences reports Q4 EPS (15c), consensus (23c)
Feb 27
8:49am ET
Wave Life Sciences announces upcoming presentations at MDA conference
Feb 02
11:07am ET
Biotech Alert: Searches spiking for these stocks today
Feb 01
1:18am ET
Strategic Investment Boosts Wave Life Sciences: A Buy Rating Amidst Market Underappreciation
Jan 22
3:20pm ET
Salim Syed Endorses Wave Life Sciences with a Buy Rating on RNA Editing Therapies’ Potential
Jan 11
1:40am ET
Leerink Partners Sticks to Its Buy Rating for Wave Life Sciences (WVE)
Jan 08
8:24am ET
Wave Life Sciences: Selection of clinical candidate in obesity planned for Q3
No recent press releases are available for WVE
WVE Financials
Key terms
Ad Feedback
WVE Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
WVE Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range